Measles Vaccine

The measles vaccine is a highly effective preventive measure against measles, a contagious viral infection. Administered as the measles, mumps, and rubella (MMR) vaccine, it provides immunity against the measles virus. The vaccine, typically given in two doses during childhood, stimulates the immune system to produce antibodies, offering long-term protection against measles. MMR vaccination not only prevents measles but also reduces the risk of complications such as pneumonia, encephalitis, and death associated with the disease. Global vaccination efforts have led to a significant decline in measles cases and related mortality. However, achieving and maintaining high vaccination coverage is crucial to prevent measles outbreaks. Measles vaccination is part of routine childhood immunization programs worldwide. In addition to routine vaccination, catch-up campaigns and supplementary immunization activities aim to close immunity gaps and eliminate measles in various regions. Despite the availability of a safe and effective vaccine, vaccine hesitancy and gaps in coverage remain challenges. Ongoing advocacy, education, and outreach efforts are essential to ensure widespread acceptance and accessibility of the measles vaccine, contributing to global efforts to eradicate this highly contagious and potentially severe infectious disease.